159
Views
7
CrossRef citations to date
0
Altmetric
Short Reports

Unusual high rate of asymptomatic maternal parvovirus B19 infection associated with severe fetal outcome

, , , , &
Pages 647-649 | Received 04 Dec 2009, Accepted 23 Jul 2010, Published online: 09 Sep 2010

References

  • Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Immunol Methods 2006;260:285–304.
  • Servey JT, Reamy BV, Hodge J. Clinical presentation of parvovirus B19 Infection. Am Fam Phys 2007;75:373–376.
  • De Haan TR, Van Weyel Meijler G, Beersma MFC, Von Lindern JS, Van Duinen SG, Walther FJ. Fetal stroke and congenital parvovirus B19 complicated by activated protein C resistance. Clin Observ 2005;95:863–865.
  • Konstantinidou AE, Syridou G, Spanakis N, Tsakis A, Agrogrianis G, Patsouris E. Association of hypospadias and cardiac defect in parvovirus B19 infection stillborn: a causality relation. J Infect 2007;54:e41–e45.
  • Glenn OA, Bianco K, Barkovich AJ, Callen PW, Parer JT. Fetal cerebellar hemorrhage in parvovirus-associated non-immune hydrops fetalis. J Matern Fetal Neonat Med 2007;20:769–772.
  • De Jong EP, De Haan TR, Kroes ACM, Beersma MFC, Oepkes D, Walther FJ. parvovirus B19 infection in pregnancy. J Clin Virol 2006;36:1–7.
  • Ergaz Z, Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol 2006;21:421–435.
  • Beigi RH, Weisenfeld HC, Landers DV, Simhan HN. High rate of severe fetal outcomes associated with maternal parvovirus B19 infection in pregnancy. Infect Dis Obstet Gynecol 2008;2008:524601.
  • Johansson S, Buchmayer S, Harlid S, Iliadou A, Sjöholm M, Grillner L, Norman M, Sparén P, Dillner J, Cnattingius S. Infection with parvovirus B19 and Herpes viruses in early pregnancy and risk of second trimester miscarriage or very preterm birth. Reprod Toxicol 2008;26:298–302.
  • Carlsen Karen Marie. Human parvovirus B19 erythrovirus. Methods established for virological and diagnostic aspects. APMIS Suppl 2006;1–121.
  • Jordan JA. Identification of human parvovirusB19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996;147:37–42.
  • Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992;99:566–574.
  • Chisaka H, Ito K, Niikura H, Sugawara J, Takano T, Murakami T, Terada Y, Okamura K, Shiroishi H, Sugamura K., et al Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 2006;209:277–283.
  • Enders M, Helbig S, Hunjet A, Pfister H, Reichhuber C, Motz M. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection. J Virol Methods 2007;146:409–413.
  • Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Söderlund-Venermo M, Hedman K. Human parvovirus B19 infection during pregnancy-value of modern molecular and serological diagnostics. J Med Virol 2006;35:400–406.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.